Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China

• Główni autorzy: Li Zeng (Autor), Huihui Chen (Autor), Heng Xiang (Autor), Mengru Zeng (Autor), Mi Zhou (Autor), Chongqing Tan (Autor), Hong Liu (Autor), Guochun Chen (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background: Rituximab (RTX) is a monoclonal antibody that selectively targets CD20 and is frequently used in the treatment of membranous nephropathy (MN). Analysis of the therapeutic efficacy and safety of RTX in treating MN in practice and a comparative pharmacoeconomic analysis of the RTX and trad...